Upstream Bio, Inc.

NASDAQ:UPB

Biotechnology

Healthcare
$2.00 +1.63%

+$0.10 today

Market cap
$109.62M
Beta
1.11
P/E (TTM)
-2.2
EPS (TTM)
-$2.89
52W Low $5.85High $33.68

Volume 0.86M

Average 0.66M

Income Statement

Follow revenue through to earnings.

Revenue

$2.85M

FY 2025 · Annual

+20.4% YoY

Operating Income

-$160.36M

FY 2025 · Annual

Net Income

-$143.44M

FY 2025 · Annual

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.21M2.38M2.37M2.85M
Cost of Revenue0000
Gross Profit1.21M2.38M2.37M2.85M
Gross Margin100.0%100.0%100.0%100.0%
Research & Development18.66M31.8M62.97M136.81M
Selling, General & Admin6.46M10.7M17.17M26.41M
Operating Expenses25.12M42.49M80.13M163.22M
Depreciation & Amortization7K60K89K188K
EBITDA(23.86M)(20.48M)(62.72M)(143.26M)
EBITDA Margin-1968.7%-860.4%-2646.3%-5019.4%
Operating Income(23.91M)(40.11M)(77.76M)(160.36M)
Operating Margin-1972.7%-1685.5%-3281.2%-5618.8%
Interest Income205K4.17M12.12M16.93M
Interest Expense0000
Other Income / Expenses41K19.58M14.96M16.92M
Income Before Tax(23.87M)(20.54M)(62.81M)(143.44M)
Pre-Tax Margin-1969.3%-862.9%-2650.0%-5026.0%
Income Tax Expense0000
Net Income(23.87M)(20.54M)(62.81M)(143.44M)
Net Margin-1969.3%-862.9%-2650.0%-5026.0%
EPS (Basic)(0.66)(1.05)(1.49)(2.66)
EPS (Diluted)(0.66)(1.05)(1.49)(2.66)
Weighted Avg Shares36.32M36.32M51.34M53.85M
Weighted Avg Shares (Diluted)36.32M36.32M51.34M53.85M

UPB Earnings Waterfall · TTM

NASDAQ:UPB · Revenue to Net Income

Key Ratios

EPS$-2.91
Gross Margin98.8%
Net Margin-4872.1%
P/E Ratio-5.7
P/S Ratio1198.2

Analysis

$3.3M of revenue converted into -$156.8M of net income for the selected period. Gross margin is 98.8% and net margin is -4872.1%, showing how much revenue survives after costs and taxes. EPS is $-2.91, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
SC 13G/ASC 13G/A filingOct 29, 2026
4Statement of changes in beneficial ownershipSep 17, 2026

How much revenue does UPB generate?

Upstream Bio, Inc. (UPB) reported $2.85M of revenue in fiscal 2025.

Is UPB profitable?

Upstream Bio, Inc. (UPB) reported -$143.44M of net income, with a net margin of -5026.0%.